TipRanks
AEPGX
American Funds EuroPacific Growth A
Advertisement

AEPGX Mutual Fund Price & Analysis

This fund primarily invests in the common stocks of companies located in Europe and the Pacific Rim, focusing on those that the investment adviser believes offer significant potential for growth. These "growth stocks" are defined as shares the adviser expects to achieve above-average capital appreciation. Under normal circumstances, at least 80% of the fund's net assets will be dedicated to securities from issuers within these European and Pacific Basin regions. A portion of the fund's holdings may also include common stocks and other financial instruments from businesses in emerging markets.

AEPGX Mutual Fund Chart & Stats

$63.07
$0.28(0.45%)
―
--
Previous Close$63.07
Sub-CategoryGlobal,International
Total Liabilities1.16B
Last Dividend Ex-Date
Jun 15, 2026
Expense Ratio0.83%
Holding Count380
Brandeupac fund
Dividend Yield
 (16.39%)
CategoryEquity
Total Assets127.93B
Shares OutstandingN/A
52-Week Range$57.17 - $72.02

AEPGX Mutual Fund News

AI Daily: Toshiba to double hard disk drive supply with AI demand booming
PremiumThe Fly
AI Daily: Toshiba to double hard disk drive supply with AI demand booming
1d ago
STX
WDC
Eutelsat advances toward launch of OneWeb renewal
PremiumThe Fly
Eutelsat advances toward launch of OneWeb renewal
2d ago
SoftBank, Nvidia make final $20B investment in OpenAI round, Information reports
PremiumThe Fly
SoftBank, Nvidia make final $20B investment in OpenAI round, Information reports
2d ago
NVDA
Summit Therapeutics enters trial collaboration with AstraZeneca, Daiichi Sankyo
PremiumThe Fly
Summit Therapeutics enters trial collaboration with AstraZeneca, Daiichi Sankyo
2d ago
AZN
SMMT
SSE Discloses Share Sale by Senior Manager Samuel Peacock
PremiumCompany Announcements
SSE Discloses Share Sale by Senior Manager Samuel Peacock
2d ago
AstraZeneca, Daiichi Sankyo and Summit expand ADC–immunotherapy push with Datroway–ivonescimab trials
PremiumCompany Announcements
AstraZeneca, Daiichi Sankyo and Summit expand ADC–immunotherapy push with Datroway–ivonescimab trials
2d ago
AZN
Barclays Keeps Their Buy Rating on AstraZeneca (AZN)
PremiumBlurbs
Barclays Keeps Their Buy Rating on AstraZeneca (AZN)
2d ago
AZN
Barclays Sticks to Its Buy Rating for SSE (SSE)
PremiumBlurbs
Barclays Sticks to Its Buy Rating for SSE (SSE)
2d ago

Top 10 Holdings

Name
Weight %
2330
TAIWAN SEMICONDUCTOR MANUFACTURING CO LTD
7.13%
USD_CASH
CAPITAL GROUP CENTRAL CASH FUND
4.26%
000660
SK HYNIX INC
2.20%
CVE
Cenovus Energy
1.99%
ASML
ASML Holding NV
1.69%
AIR
Airbus Group
1.61%
AZN
AstraZeneca plc
1.59%
UCG
UniCredit S.p.A
1.36%
9984
SoftBank Group Corp
1.22%
SSE
Sse Plc (UK)
1.14%
Total24.20%
Go to Holdings >

Recently Viewed

Become an Expert with TipRanks Premium
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis
Subscribe NowSee Plans & Pricing
Advertisement